R&D LNPs: The unknown enabler behind mRNA vaccines Drug delivery technologies are crucial to allow drugs to reach their full potential, and yet they rarely receive much spotlight.
Events Partner Content Next Generation Lipid-Based Nanoparticles Delivery Summit | ... Harness Safe & Efficacious Lipid-Based Delivery for Novel Therapeutics Beyond RNA & Hepatic Tissue
News Otsuka grows in neuroplastogens with $1.225bn Transcend buy Otsuka has agreed to acquire Transcend Therapeutics and its MDMA-based neuroplastogen drug candidate for PTSD, heading for phase 3 trials.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
